奥贝胆酸对非酒精性脂肪肝大鼠法尼醇X受体及细胞色素P450家族成员7A1基因表达的影响

林浩 梁大伟 曾建峰 李述剑 王建福 李飞

解剖学报 ›› 2018, Vol. 49 ›› Issue (1) : 49-55.

PDF(644 KB)
欢迎访问《解剖学报》官方网站!今天是 English
PDF(644 KB)
解剖学报 ›› 2018, Vol. 49 ›› Issue (1) : 49-55. DOI: 10.16098/j.issn.0529-1356.2018.01.008
细胞和分子生物学

奥贝胆酸对非酒精性脂肪肝大鼠法尼醇X受体及细胞色素P450家族成员7A1基因表达的影响

  • 林浩1 梁大伟1* 曾建峰2 李述剑3 王建福4 李飞1
作者信息 +

Effect of obeticholic acid on expression of farnesoid X receptor and cytochrome 7A1 in nonalcoholic fatty liver rats

  • LIN Hao1 LIANG Da-wei 1* ZNEG Jian-feng2 LI Shu-jian3 WANG Jian-fu4 LI Fei1
Author information +
文章历史 +

摘要

目的 探讨奥贝胆酸对非酒精性脂肪肝(NAFLD)大鼠法尼醇X受体(FXR)蛋白、细胞色素P450家族成员7A1(CYP 7A1)蛋白及其基因表达的影响,及保肝作用。 方法 雄性SD大鼠52只通过高脂饲料喂养建立大鼠非酒精性脂肪肝模型;设置对照组11只,模型组、奥低组、奥中组和奥高组共41只,给药4周后,取大鼠相同部位肝脏,免疫组织化学法测定FXR蛋白表达、RT-PCR检测FXR mRNA,Western blotting法检测CYP 7A1蛋白、RT-PCR检测CYP 7A1 mRNA的表达水平;通过大鼠肝指数,外周血谷丙转氨酶(ALT)、谷草转氨酶(AST)和碱性磷酸酶(ALP)的浓度,及肝脏组织切片观察,评估肝功能。 结果 高脂饲料喂养10周后,大鼠具有典型的NAFLD特征,模型建立成功。模型组的FXR蛋白和FXR mRNA表达水平显著低于对照组(P<0.05),奥低组和奥中组的FXR蛋白和FXR mRNA表达水平与模型组相比,差异无统计学意义(P>0.05),奥高组的FXR蛋白和FXR mRNA表达水平显著高于模型组(P<0.05);模型组、奥低组和奥中组的吸光度值显著低于对照组(P<0.05),奥高组显著升高,与对照组差异无统计学意义(P>0.05)。模型组的CYP 7A1蛋白和CYP 7A1 mRNA表达水平显著高于对照组(P<0.05),奥低组和奥中组的CYP 7A1蛋白和CYP 7A1 mRNA的表达水平与模型组相比,差异无统计学意义(P>0.05),奥高组的CYP 7A1蛋白和CYP 7A1 mRNA表达水平显著低于模型组(P<0.05)。与对照组相比,模型组的肝指数(%)显著增大(P<0.05);奥低组和奥中组的肝指数(%)与模型组相比,差异无统计学意义(P>0.05),奥高组肝指数(%)显著低于模型组(P<0.05)。与对照组相比,模型组的ALT、AST和ALP的浓度显著升高(P<0.05);奥贝胆酸组的ALT、AST和ALP浓度显著低于模型组(P<0.05),且随着奥贝胆酸给药量的增加,ALT、AST和ALP的浓度逐渐降低;肝组织切片观察结果显示,奥贝胆酸呈剂量依赖性改善大鼠肝组织。 结论 奥贝胆酸高剂量能显著上调FXR蛋白及其基因的表达,并抑制CYP 7A1蛋白及其基因的表达,显著改善大鼠肝功能及肝组织病理状态。

Abstract

Objective To investigate the effect of obeticholic acid on protein expression and gene expression of farnesolid X receptor (FXR), cytochrome 7A1 (CYP 7A1) in non-alcohol fatty liver disease (NAFLD) rat and hepatocyteprotective effect. Methods Fifty two SD rats of the non-alcoholic fatty liver model was established by feeding with high-fat diet. The control group, model group,the experimental group(low), the experimental group(middle), the experimental group(high) were set up. After four weeks of administration, the same part of the liver was taken out. The expression of FXR protein was detected by immunohistochemistry method , the mRNA expression of FXR was detected by RT-PCR, the protein CYP7A1 was detected by Western blotting and the mRNA expression of CYP7A1 was detected by RT-PCR. The liver function was assessed by the rat liver index of the concentrations of peripheral blood alanine aminotransferase (ALT), aspartate transaminase(AST) and alkaline phosphatase(ALP), and the observation of liver sections. Results After fed with high-fat diet for 10 weeks, the rats had typical characteristics of NAFLD and the model was established successfully. The expression of FXR protein and FXR mRNA in the model group were significantly lower than that in the control group (P<0.05). There was no significant difference in the expression of FXR protein and FXR mRNA between the experimental group(low) and the experimental group(middle) (P> 0.05). The expression of FXR protein and FXR mRNA in the experimental group(high) was significantly higher than that in model group (P<0.05). The optical density values of model group, the experimental group(low), and the experimental group(middle) were significantly lower than those of control group (P<0.05). The optical density values of the experimental group(high) was significantly higher, and there was no significant difference compared with those of the control group (P>0.05). The CYP7A1 protein and CYP7A1 mRNA expression levels in the model group were significantly higher than those in the control group (P<0.05). Compared with those in the model group, the expression levels of CYP7A1 protein and CYP7A1 mRNA in the experimental group(low) and the experimental group(middle) had no significant difference (P>0.05). The levels of CYP 7A1 protein and CYP 7A1 mRNA in the experimental group(high) were significantly lower than those in the model group (P<0.05). Compared with the control group, the liver index (%) of the model group increased significantly (P<0.05), while the liver index (%) of the experimental group(low) and the experimental group(middle) had no significant difference compared with the model group (P> 0.05). The liver index (%) of the experimental group(high) was significantly lower than that of the model group (P<0.05). Compared with the control group, the concentrations of ALT, AST and ALP in the model group were significantly increased (P<0.05). The levels of ALT, AST and ALP in the experimental group were significantly lower than those in model group (P<0.05), and the concentrations of ALT, AST and ALP gradually decreased with the increase of acyclobacic acid dosage. The liver tissue sections were observed. The result showed that obeticholic acid improved the histopathology of rats in a dose-dependent manner. Conclusion High doses of acyclobacic acid can significantly upregulate the expression of FXR protein and its gene, inhibit the expression of CYP 7A1 protein and its gene, and significantly improve the liver function and pathological status of rats.

关键词

奥贝胆酸 / 非酒精性脂肪肝 / 法尼醇X受体蛋白 / 细胞色素7A1蛋白 / 免疫印迹法 / 大鼠

Key words

Obeticholic acid / Non-alcoholic fatty liver / Farnesoid X receptor / Cytochrome 7A1 protein / Western blotting / Rat

引用本文

导出引用
林浩 梁大伟 曾建峰 李述剑 王建福 李飞. 奥贝胆酸对非酒精性脂肪肝大鼠法尼醇X受体及细胞色素P450家族成员7A1基因表达的影响[J]. 解剖学报. 2018, 49(1): 49-55 https://doi.org/10.16098/j.issn.0529-1356.2018.01.008
LIN Hao LIANG Da-wei ZNEG Jian-feng LI Shu-jian WANG Jian-fu LI Fei. Effect of obeticholic acid on expression of farnesoid X receptor and cytochrome 7A1 in nonalcoholic fatty liver rats[J]. Acta Anatomica Sinica. 2018, 49(1): 49-55 https://doi.org/10.16098/j.issn.0529-1356.2018.01.008

参考文献

[1]Sattar N, Forrest E, Preiss D. Non-alcohol fatty liver disease [J]. BMJ, 2014,349:g4596.
[2]Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China [J]. J Heaptol, 2009,50(1):204-210.
[3]Ma FCh, Zhang QY, Wang Sh, et al. Animal model of nonalcoholic fatty liver disease: research advances [J]. Journal of International Phammaceutical Research, 2017, 44(5):409-414. (in Chinese)
马富超, 张泉洋, 王帅, 等. 非酒精性脂肪肝病动物模型研究进展[J]. 国际药学研究杂志, 2017, 44(5): 409-414.  
[4]Li Q, Fu JH. Animal model of nonalcoholic fatty liver disease: research advances [J]. Practical Clinical Journal of Integrate Traditional Chinese and Western Medicine, 2013, 13(3):92-94. (in Chinese)
李强, 傅继华. 非酒精性脂肪肝动物模型研究进展[J]. 实用中西医结合临床, 2013,13(3):92-94. 
[5]Zhang HB, Wang Y. Research progress of non-alcoholic fatty liver disease [J]. Hainan Medical Journal, 2017, 28(10):1651-1653. (in Chinese)
张海博, 王宇. 非酒精性脂肪肝的现代研究进展[J]. 海南医学, 2017, 28(10):1651-1653.  
[6]Zhang L, Niu ShM, Ma HJ. The Progress of bile acids and metabolic syndrome [J]. Medical Recapitulate, 2016, 22(5): 964-967. (in Chinese)
张柳, 牛尚梅, 马慧娟. 胆汁酸与代谢综合征的研究进展[J]. 医学综述, 2016, 22(5):964-967. 
[7]Bonapace S, Perseghin G, Molon G, et al. Nonalcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in patients with type 2 diabetes [J]. Diabetes Care, 2012,35(2):389-395.
[8]Bechmann LP, Kocabayoglu P, Sowa JP, et al. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis [J]. Hepatology, 2013, 57(4):1394-406.
[9]Liu ST, Liao HY. Clinical research progress of obeticcholic acid [J]. Beijing Medical Journal, 2015, 37(12): 1174-1176. (in Chinse)
刘松涛, 廖慧钰. 奥贝胆酸的临床研究进展[J]. 北京医学, 2015, 37(12): 1174-1176. 
[10]Bjursell M, Wedin M, Admyre T, et al. Ageing FXR deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH [J]. PLoS One, 2013, 8(5):e64721.
[11]Ma Y, Huang Y, Yan L, et al. Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance [J]. Pharm Res, 2013, 30(5):1447-1457.
[12]Schaap FG, Trauner M, Jansen PL. Bile acid receptors as targets for drug development [J]. Nat Rev Gastroenterol Hepatol, 2014, 11(1):55-67.
[13]Chen ShQ, Zhang J, Fang QCh. Recent progress of the role of bile acids in regulating glucose, lipid and energy metabolism [J]. Medical Recapitulate, 2016, 22(5):947-950. (in Chinese)
陈淑芹, 张菁, 方启晨. 胆汁酸对糖脂及能量代谢调节作用的研究进展[J]. 医学综述, 2016, 22(5):947-950.  
[14]Neuschwander-Tetri BA, Loomba R, Sanyal AJ, et al. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial [J]. Lancet, 2015, 385(9972):956-965.

PDF(644 KB)

Accesses

Citation

Detail

段落导航
相关文章

/